CymitQuimica logo

CAS 2002-44-0

:

L-Prolyl-L-leucylglycinamide

Description:
L-Prolyl-L-leucylglycinamide, with the CAS number 2002-44-0, is a synthetic peptide that consists of three amino acids: proline, leucine, and glycine. This compound is characterized by its specific sequence, which influences its biological activity and interactions. Peptides like L-Prolyl-L-leucylglycinamide are often studied for their potential roles in various physiological processes, including their effects on neurotransmission and hormone regulation. The presence of proline in its structure can contribute to unique conformational properties, potentially affecting its stability and solubility. Additionally, the hydrophobic nature of leucine may influence its interactions with biological membranes or proteins. L-Prolyl-L-leucylglycinamide may also exhibit specific binding affinities to receptors, making it of interest in pharmacological research. Overall, the characteristics of this compound, including its amino acid composition and sequence, play a crucial role in determining its functionality and potential applications in biochemistry and medicinal chemistry.
Formula:C13H24N4O3
InChI:InChI=1/C13H24N4O3/c1-8(2)6-10(12(19)16-7-11(14)18)17-13(20)9-4-3-5-15-9/h8-10,15H,3-7H2,1-2H3,(H2,14,18)(H,16,19)(H,17,20)/t9-,10-/m0/s1
InChI key:InChIKey=NOOJLZTTWSNHOX-UWVGGRQHSA-N
SMILES:[C@@H](NC(=O)[C@@H]1CCCN1)(C(NCC(N)=O)=O)CC(C)C
Synonyms:
  • 2-Pyrrolidinecarboxamide, N-[1-[(carbamoylmethyl)carbamoyl]-3-methylbutyl]-
  • 26: PN: US6093797 PAGE: 15 claimed protein
  • 27: PN: US6093797 PAGE: 15 claimed protein
  • 2: PN: WO2009039992 PAGE: 107 claimed protein
  • 7-9-Oxytocin
  • <span class="text-smallcaps">L</smallcap>-Proline-<smallcap>L</span>-leucine-glycine-amide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucyl-glycine amide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucylglycinamide
  • <span class="text-smallcaps">L</smallcap>-Prolyl-<smallcap>L</span>-leucylglycylamide
  • Glycinamide, <span class="text-smallcaps">L</smallcap>-prolyl-<smallcap>L</span>-leucyl-
  • See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
  • Melanocyte-Stimulating Hormone-Release Inhibiting Factor
    Bachem
    + Info

    Melanocyte-Stimulating Hormone-Release Inhibiting Factor

    CAS:
    MIF-I, the C-terminal tripeptide of oxytocin, has been shown to be active in numerous behavioral tests and clinical situations.
    Formula:C13H24N4O3
    Purity:> 99%
    Color and Shape:White
    Molecular weight:284.36

    Ref: 01-4000343

    1g
    129.00€
    5g
    493.00€
  • H-PRO-LEU-GLY-NH2
    Indagoo
    + Info

    H-PRO-LEU-GLY-NH2

    CAS:
    Formula:C13H24N4O3
    Purity:95%
    Color and Shape:Solid
    Molecular weight:284.3547

    Ref: IN-DA00BCS5

    10mg
    125.00€
    50mg
    208.00€
    100mg
    330.00€
    250mg
    582.00€
  • (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide
    Fluorochem
    + Info

    (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide

    CAS:
    Formula:C13H24N4O3
    Purity:95.0%
    Molecular weight:284.36

    Ref: 10-F242063

    1g
    378.00€
    250mg
    212.00€
  • MSH-Release Inhibiting Factor
    Biosynth
    + Info

    MSH-Release Inhibiting Factor

    CAS:
    <p>MSH-Release Inhibiting Factor (MRIF) has been shown to be a potent inhibitor of the release of proinflammatory cytokines. It is derived from the acid methyl ester of mouse serum, and has been shown to inhibit the release of tumor necrosis factor-α (TNF-α) in animal studies. MRIF has also been shown to have anti-diabetic effects in mice. MRIF inhibits the production of inflammatory cytokines by blocking TNF-α at a molecular level. This protein binds to progesterone receptor and prevents it from interacting with its ligand, which is necessary for cancer cell growth. The expression system for this protein is E. coli, and it can be used as an immunosuppressant in animal studies.<br>MRIF also blocks TNF-α activity by inhibiting transcriptional activation of NFκB and AP-1, which are proteins that regulate gene expression.</p>
    Formula:C13H24N4O3H2O
    Purity:Min. 95%
    Molecular weight:293.36 g/mol

    Ref: 3D-PMI-4024

    25mg
    158.00€
    100mg
    162.00€
  • Melanocyte-Stimulating Hormone-Release Inhibiting Factor
    Biosynth
    + Info

    Melanocyte-Stimulating Hormone-Release Inhibiting Factor

    CAS:
    <p>Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MSH-RF) is a synthetic peptide that inhibits the release of melanin from melanocytes. MSH-RF has been shown to be a useful treatment for melatonin deficiency, which may be related to immune system disorders such as infectious diseases and autoimmune diseases. It has also been shown to have significant interactions with other hormones such as dopamine, affecting locomotor activity and the ph optimum, among other biological properties. The structure of MSH-RF has been determined using X-ray crystallography on an amide bond. This peptide hormone is found in human serum and is involved in regulating camp levels.</p>
    Formula:C13H24N4O3
    Purity:Min. 95%
    Molecular weight:284.35 g/mol

    Ref: 3D-FM109235

    2g
    863.00€
    5g
    1,052.00€